.Merck trumps revenues assumptions, brings up purchases outlook on tough demand for top drugs like Keytruda CNBCMerck & Co. (MRK United States) Defeats Revenue Projections as Keytruda Purchases Growth BloombergMerck Supply: Pharma Titan Posts Strong Results, Yet Expectation Drops Short Financier's Service DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats revenue and also sales requirements among Keytruda asset, however provides mixed full-year overview MarketWatch.